Anzeige
Meldung des Tages: Diese Zahlen lügen nicht: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

OSR News

Aktie
WKN:  A411DT ISIN:  US68840D1028 US-Symbol:  OSRH Branche:  Biotechnologie Land:  USA
0,57 $
+0,0065 $
+1,15%
0,48453 € 17.04.26
Depot/Watchlist
Marktkapitalisierung *
10,38 Mio. €
Streubesitz
52,35%
KGV
-0,60
Index-Zuordnung
-

OSR News

19.03.26 - PR Newswire
Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials
Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials PR Newswire
22.01.26 - PR Newswire
Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch
Woori IO, an OSR Company, Highlights FDA Clarification on Non-​Medical Wearables as a Catalyst for Accelerated Commercial Launch PR Newswire
16.01.26 - PR Newswire
Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform
Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-​Generation Oral Immunotherapy Platform PR Newswire
12.01.26 - PR Newswire
Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones
Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones PR Newswire
19.12.25 - PR Newswire
Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings
Woori IO Shareholders Approve Share Exchange to Become Wholly-​Owned Subsidiary of OSR Holdings PR Newswire
02.12.25 - PR Newswire
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months PR Newswire
01.12.25 - PR Newswire
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025 PR Newswire
21.11.25 - PR Newswire
Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones
Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones PR Newswire
14.11.25 - PR Newswire
OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion
OSR Holdings Appoints Scientific Co-​Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-​Oncology Expansion PR Newswire
06.11.25 - PR Newswire
OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study
OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-​Sponsored Pilot Study PR Newswire
14.10.25 - PR Newswire
OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care
OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care PR Newswire
09.09.25 - PR Newswire
OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity
OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity PR Newswire
01.08.25 - PR Newswire
OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025
OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025 PR Newswire
31.07.25 - PR Newswire
OSR Holdings Provides Transparency Update on Equity Financing Instruments
OSR Holdings Provides Transparency Update on Equity Financing Instruments PR Newswire
30.07.25 - PR Newswire
OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure
OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure PR Newswire
24.07.25 - PR Newswire
OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology
OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology PR Newswire
15.07.25 - PR Newswire
OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company
OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company PR Newswire
09.07.25 - PR Newswire
OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG
OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG PR Newswire
09.07.25 - PR Newswire
OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG
OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG PR Newswire
08.07.25 - PR Newswire
OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG
OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG PR Newswire

Newssuche

Videos

newspaper
16.04.26 +2,80%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »